Injective vs ZkSync — how do they compare? Injective trades at Rp91,720 (market cap Rp9,15T, Rp1,96T 24h volume), while ZkSync trades at Rp181.28 (market cap Rp1,83T, Rp210,78M 24h volume). The key difference: Injective is far larger — about 5× ZkSync's market cap, and ZkSync's supply is capped (10,1B / 21B ZK (48%)) while Injective's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Injective for 36 Days and ZkSync for 16 Days on average.
| INJ | ZK | |
|---|---|---|
Market Cap | Rp9,15T | Rp1,83T |
Volume (24h) | Rp1,96T | Rp210,78M |
Circulating Supply | 100M INJ | 10,1B / 21B ZK (48%) |
Typical Hold Time | 36 Days | 16 Days |
Signals from Pluang's Aura AI — not financial advice
Injective (INJ) is trading at Rp92,221 with a market cap of Rp9.18T, showing a bullish technical signal overall. The moving averages are strongly bullish, while oscillators are neutral. Key resistance lies at Rp93,589 and support at Rp86,188. The asset has a hold time of 36 days, indicating moderate holding behavior. No major protocol updates or ecosystem news are noted recently, but the token remains active in decentralized exchange and DeFi sectors.
Overall outlook is cautiously optimistic due to bullish technicals, but risks include high volatility and neutral oscillators suggesting potential consolidation. Opportunities lie in continued ecosystem growth, while major risks involve crypto market sentiment shifts and regulatory uncertainties. Investors should monitor key resistance levels for breakout signals.
ZK is currently trading at Rp184,183 with a market cap of Rp1.85 trillion, showing a bearish technical signal driven by moving averages while oscillators remain neutral. The token's circulating supply is 10.1 million out of a 21 million max supply, with a circulation rate of 48%. Recent ecosystem activity includes protocol updates aimed at scaling solutions, though no major fundamental developments were reported in the last month.
Overall outlook is cautious due to bearish technical indicators and neutral sentiment. Key opportunities lie in potential network adoption growth, while risks include high volatility and regulatory uncertainty. Investors should monitor support at Rp177 and resistance at Rp192 for near-term price action.
What Pluang investors did over the last 30 days
Latest headlines on both assets
Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.
Read more on INJ →ZKsync is a trustless Layer 2 protocol for scalable low-cost payments on Ethereum, powered by zkRollup technology. It is a user-centric zk rollup platform from Matter Labs. Its key features and products include: ZKsync Era, SDKs, ZKsync Node, ZK Stack, and zkEVM.
Read more on ZK →